Skylight Health Group - Technology-Driven Healthcare Skylight Health Group holding above $1.30 after announcing a partnership with ClinEdge for clinical trials in the US. This partnership will benefit Skylight financially as the award for clinical research sites may range from $1,000 - $15,000 per patient per trial. The $SHG stock has been holding steady up 30%+ since hitting the bottom in March. Their healthcare technology is aimed to improve patient health outcomes in their multi-state clinic network.
The technology-driven primary healthcare sector is heating up with new IPOs backed by some of the largest companies in the world.
Privia Health ($PRVA) - $100M IPO with Goldman Sachs, J.P. Morgan, Credit Suisse, Piper Sandler and William Blair being the joint bookrunners on the deal
https://www.businesswire.com/news/home/20210407005713/en/Privia-Health-Announces-Filing-of-Registration-Statement-for-Proposed-Initial-Public-Offering
VillageMD - Backed by Walgreens receiving a $1B investment last year.
https://www.google.ca/amp/s/www.forbes.com/sites/brucejapsen/2021/04/08/walgreens-backed-villagemd-could-be-latest-primary-care-ipo/amp/
$SHG's operations span 16 states across the US serving over 155,000 patients. The company has been acquiring many new clinics and is expanding its operations every month. The company has been steadily growing and is ready to do $56M+ in revenue when they close all the acquisitions in their $100M pipeline.
https://ca.finance.yahoo.com/news/skylight-health-announces-partnership-clinedge-110000521.html